Karen Swider is a notable inventor based in West Conshohocken, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of microcrystalline cellulose particles. With a total of 2 patents, her work has advanced the way active drugs are formulated and delivered.

Latest Patents

Karen Swider's latest patents include innovative methods for creating microcrystalline cellulose particles that serve as a core for active drugs. The first patent focuses on the solution coating of an active drug onto a predominately microcrystalline cellulose core. This method results in coated particles that exhibit a narrower particle size distribution compared to those produced by other processes. Additionally, an optional final coating of a pharmaceutically acceptable polymeric material can be applied for tastemaking, controlled release, and protection of the drug-layered particles. The second patent mirrors this approach, emphasizing the importance of particle size distribution and the benefits of the final coating.

Career Highlights

Karen Swider is currently employed at McNeil-PPC, Inc., where she continues to innovate in the pharmaceutical sector. Her work has not only contributed to her personal achievements but has also enhanced the capabilities of her organization in drug formulation.

Collaborations

Throughout her career, Karen has collaborated with esteemed colleagues such as Indukumar G Shah and Daniel McTeigue. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Karen Swider's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as a leading inventor. Her innovative approaches to drug formulation continue to impact the industry positively.